93
Views
4
CrossRef citations to date
0
Altmetric
Original Research

The Risk Assessment and Clinical Research of Bile Duct Injury After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma

, &
Pages 5039-5052 | Published online: 28 Jun 2021

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.30207593
  • Takayasu K, Arai S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131(2):461–469. doi:10.1053/j.gastro.2006.05.021.16890600
  • Zhou J, Sun HC, Wang Z, et al. Guidelines for the diagnosis and treatment of Hepatocellular Carcinoma (2019 Edition). Liver Cancer. 2020;9(6):682–720. doi:10.1159/000509424.33442540
  • Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164–1171. doi:10.1053/jhep.2002.33156.11981766
  • Makary MS, Khandpur U, Cloyd JM, et al. Locoregional therapy approaches for Hepatocellular carcinoma: recent advances and management strategies. Cancers. 2020;12(7):1914. doi:10.3390/cancers12071914.
  • Varela M, Real MI, Burrell M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol. 2007;46(3):474–481. doi:10.1016/j.jhep.2006.10.020.17239480
  • Gupta S, Johnson MM, Murthy R, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer. 2005;104(8):1590–1602. doi:10.1002/cncr.21389.16134179
  • Sueyoshi E, Hayashida T, Sakamoto I, et al. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Roentgenol. 2010;195(1):245–251. doi:10.2214/AJR.08.2301.20566824
  • Chung JW, Park JH, Han JK, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 1996;198(1):33–40. doi:10.1148/radiology.198.1.8539401.8539401
  • Tarazov PG, Polysalov VN, Prozorovskij KV, et al. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiologica. 2000;41(2):156–160. doi:10.1080/028418500127344966.10741789
  • Kim HK, Chung Y-H, Song B-C, et al. Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol. 2001;32(5):423–427. doi:10.1097/00004836-200105000-0001311319315
  • Komatsu M, Fujii T, Goto T, et al. Giant hepatic biloma following transcatheter oily chemoembolization in a patient with hepatic metastases from malignant pheochromocytoma. Internal Med. 1998;37(12):1034–1038. doi:10.2169/internalmedicine.37.1034.9932636
  • Pua U. Transarterial chemoembolization induced main duct stricture. Clin Gastroenterol Hepatol. 2011;9(12):A22. doi:10.1016/j.cgh.2011.06.025.
  • Kondo Y, Shiina S, Tateishi R, et al. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient’s prognosis. Liver Int. 2011;31(2):197–205. doi:10.1111/j.1478-3231.2010.02415.x.21159122
  • Bhagat N, Reyes DK, Lin M, et al. Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury. Cardiovasc Intervent Radiol. 2013;36(2):449–459. doi:10.1007/s00270-012-0424-y.
  • EASL-EORTC. Clinical practice guidelines. Management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943. doi:10.1016/j.jhep.2011.12.001.22424438
  • Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359(9319):1734–1739. doi:10.1016/S0140-6736(02)08649-X.12049862
  • Chung J, Yu JS, Chung JJ, et al. Hemodynamic events and localised parenchymal changes following transcatheter arterial chemoembolization for hepatic malignancy: interpretation of imaging findings. Br J Radiol. 2010;83(985):71–81. doi:10.1259/bjr/82377365.19581309
  • Yu JS, Kim KW, Jeong MG, et al. Predisposing factors of bile duct injury after transcatheter arterial chemoembolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol. 2002;25(4):270–274. doi:10.1007/s00270-001-0049-z.12042987
  • Yu JS, Kim KW, Park MS, et al. Bile duct injuries leading to portal vein obliteration after transcatheter arterial chemoembolization in the liver: CT findings and initial observations. Radiology. 2001;221(2):429–436. doi:10.1148/radiol.2212010339.11687687
  • Bang BW, Lee DH, Jeong S, et al. Ischemic biliary stricture developed after repeated transcatheter arterial chemoembolization diagnosed by percutaneous transhepatic cholangioscopy in a patient with hepatocellular carcinoma. Gastrointest Endosc. 2008;68(6):1224–1226. doi:10.1016/j.gie.2008.03.004.18555248
  • Makuuchi M, Sukigara M, Mori T, et al. Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology. 1985;156(2):331–334. doi:10.1148/radiology.156.2.2989972.2989972
  • Kobayashi S, Nakanuma Y, Terada T, Matsui O. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus. Am J Gastroenterol. 1993;88(9):1410–1415.8395764
  • Miyayama S, Yamashiro M, Hashimoto M, et al. Blood supply of the main bile duct from the caudate artery and medial subsegmental artery of the hepatic artery: evaluation using images obtained during transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatol Res. 2013;43(11):1175–1181. doi:10.1111/hepr.12071.23387506
  • Miyayama S, Yamashiro M, Okuda M, et al. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2010;33(6):1168–1179. doi:10.1007/s00270-009-9781-6.20058008
  • Guiu B, Deschamps F, Aho S, et al. Liver/biliary injuries following chemoembolization of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol. 2012;56(3):609–617. doi:10.1016/j.jhep.2011.09.012.22027582
  • Spina JC, Ulla M, Yeyati EL, et al. MDCT findings after hepatic chemoembolization with DC-beads: what the radiologist needs to know. Abdom Imaging. 2013;38(4):778–784. doi:10.1007/s00261-012-9963-6.23053454
  • Kobayashi S, Kozaka K, Gabata T, et al. Pathophysiology and imaging findings of bile duct necrosis: a rare but serious complication of transarterial therapy for liver tumors. Cancers. 2020;12(9):2596. doi:10.3390/cancers12092596.
  • Alabdulghani F, Healy GM, Cantwell CP, et al. Radiological findings in ischaemic cholangiopathy. Clin Radiol. 2020;75(3):161–168. doi:10.1016/j.crad.2019.10.017.
  • Cui J, de Klerk N, Abramson M, et al. Fractional polynomials and model selection in generalized estimating equations analysis, with an application to a longitudinal epidemiologic study in Australia. Am J Epidemiol. 2009;169(1):113–121. doi:10.1093/aje/kwn292.18990716
  • Chen W, Ying D, Liu Z, He Z. Analysis of the arterial supply of the extrahepatic bile ducts and its clinical significance. Clin Anatomy. 1999;12(4):245–249. doi:10.1002/(SICI)1098-2353(1999)12:4<245::AID-CA2>3.0.CO;2-W.
  • Gunji H, Cho A, Tohma T, et al. The blood supply of the hilar bile duct and its relationship to the communicating arcade located between the right and left hepatic arteries. Am J Surg. 2006;192(3):276–280. doi:10.1016/j.amjsurg.2006.01.046.16920417
  • Strasberg SM, Helton WS. An analytical review of vasculobiliary injury in laparoscopic and open cholecystectomy. HPB (Oxford). 2011;13(1):1–14. doi:10.1111/j.1477-2574.2010.00225.x.
  • Lang E, Brown C. Colorectal metastases to the liver: selective chemoembolization. Radiology. 1993;189(2):417–422. doi:10.1148/radiology.189.2.8210369.8210369
  • Therasse E, Breittmayer F, Roche A, et al. Transcatheter chemoembolization of progressive carcinoid liver metastasis. Radiology. 1993;189(2):541–547. doi:10.1148/radiology.189.2.7692465.7692465
  • Sakamoto I, Iwanaga S, Nagaoki K, et al. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. Am J Roentgenol. 2003;181(1):79–87. doi:10.2214/ajr.181.1.1810079.12818833
  • Boulin M, Adam H, Guiu B, et al. Predictive factors of transarterial chemoembolization toxicity in unresectable hepatocellular carcinoma. Dig Liver Dis. 2014;46(4):358–362. doi:10.1016/j.dld.2013.12.012.24462550
  • Thompson CM, Saad NE, Quazi RR, et al. Management of iatrogenic bile duct injuries: role of the interventional radiologist. Radiographics. 2013;33(1):117–134. doi:10.1148/rg.331125044.23322833